Non-communicable disease management in vulnerable patients during Covid-19

Indoor Air Quality and Severity of COVID-19: Where Communicable and Non-communicable Preventive Measures Meet

Strategic Management of Disease Covid-19

Introduction: Following the outbreak of Qovid-19, many studies have been published rapidly on research sites and scientific literature around the world. This study aimed to investigate the strategies of this epidemic. This study was conducted in a structured review method without statistical analysis that was conducted by searching related studies and resources in databases of Web of Science an...

Hematology findings in patients with Coronavirus disease 2019 (COVID-19)

In December 2019, Wuhan, the capital of Hubei Province in China, became the center of an outbreak of pneumonia with unknown etiology. By 7 January 2020, Chinese scientists have isolated a new coronavirus from patients with viral infectious pneumonia, the Coronavirus 2 Acute Respiratory Syndrome (SARS-CoV-2), previously called 2019-nCoV. The disease was later diagnosed as coronavirus 2019 (COVID...

Treatment adherence in chronic patients during the Covid-19 pandemic

Introduction: The spread of the  (COVI-19) pandemic caused the creation of medical services and attention in health care, especially for patients with chronic diseases. Therefore, this study was conducted with the aim of determining adherence to treatment in chronic patients during daily covid-19. Materials and methods: In this cross-sectional study, 214 cases of people suffering from chronic d...

COVID-19 Intervention Scenarios for a Long-term Disease Management

Background The first outbreak of coronavirus disease 2019 (COVID-19) was successfully restrained in many countries around the world by means of a severe lockdown. Now, we are entering the second phase of the pandemics in which the spread of the virus needs to be contained within the limits that national health systems can cope with. This second phase of the epidemics is expected to last until a...